Bobby Steggert Mothers and Sons Jim Parsons Star Files Tyne Daly View Comments Show Closed This production ended its run on June 22, 2014 Related Shows Frederick Weller View All (4) Ding-dong. Who’s there? Why, it’s Jim Parsons! The star of HBO’s The Normal Heart stopped by the Golden Theatre to pay a visit to Mothers and Sons stars Tyne Daly, Bobby Steggert, Frederick Weller and Grayson Taylor on May 14. The Tony-nominated play by Terrence McNally centers on Katharine (Daly), a mother who turns up at the door of her son’s former lover twenty years after her son’s death. After witnessing the heartbreaking and funny story, the Big Bang Theory fave and Harvey alum stopped backstage to greet the cast. Check out these photos from the Emmy winner’s visit, then catch Mothers and Sons on Broadway!
Show Closed This production ended its run on Jan. 4, 2015 Related Shows Wow, would you look at the baby blues on these two? Ewan McGregor and Maggie Gyllenhaal, the talented (and did we mention gorgeous?) new stars of The Real Thing make a perfect pair in this promotional image for the new production. Directed by Sam Gold, the new revival of Tom Stoppard’s drama also stars Cynthia Nixon and Josh Hamilton. The Real Thing tells the story of Henry (McGregor), a successful playwright who is unhappily married to Charlotte (Nixon), the lead actress in his current play about a marriage on the verge of collapse—meanwhile, Henry’s affair with their friend Annie (Gyllenhaal) threatens to destroy her own marriage. Check out this sweet shot of the stars, then see them make their Broadway debuts in The Real Thing at the American Airlines Theatre! The Real Thing View Comments
And I And Silence The Signature Theatre production stars Trae Harris as Young Jamie, Rachel Nicks as Jamie, Emily Skeggs as Young Dee and Samantha Soule as Dee. And I and Silence explores the fierce dreams of youth and the brutal reality of adulthood in 1950’s America. Two imprisoned teenagers, one black, one white, form a perilous bond. As the young women serve time, they forge a plan for survival. When the outside world proves even more dangerous than the jail itself, their private world becomes an untenable practice ground for their new lives. View Comments The U.S. premiere of Naomi Wallace’s And I and Silence begins performances on August 5. The production, directed by Caitlin McLeod, will open officially on August 25 in the Romulus Linney Courtyard Theatre at the Pershing Square Signature Center. The play will run through September 14. Related Shows Show Closed This production ended its run on Sept. 14, 2014
View Comments Feel the Romance at An American in Paris Begins March 13 at the Palace Theatre Terrific things come from Paris: fashion, fattening desserts, and easy-to-imitate accents. Add another. After a stint in the city of lights, An American in Paris—based on the classic 1951 Gene Kelly musical—finally begins performances on Broadway soil. Get ready for terrific dancing (led by Robert Fairchild, Megan’s brother), enchanting George Gershwin music, and old school romance aplenty. This was practically made for date night, so ditch the Netflix and get going. Click for tickets! Spend the Morning with Elisabeth Moss March 12 on ABC Elisabeth Moss is currently starring in The Heidi Chronicles and is in the upcoming final season of Mad Men. So, there will be tons to discuss when she chats with Kelly and Michael. It should be a good time. We only hope that Moss knows it’s present day and doesn’t walk out in a suit with giant shoulder pads or some other early ‘90s fashion atrocity. Let’s hope she reads this! Lose Yourself at Finding Neverland Begins March 15 at the Lunt-Fontanne Theatre Aside from being a terrific peanut butter, Peter Pan is an amazing story. Author J.M. Barrie’s journey to his artistic achievement, however, is equally compelling. Glee’s Matthew Morrison returns to Broadway as Barrie, a tortured soul whose creative and personal life turns around when he meets widow Sylvia Llewelyn Davies (Laura Michelle Kelly) and her four boys. Kelsey Grammer, Carolee Carmello, and Teal Wicks also star in this new musical. Click for tickets! Kick Off Spring with the Rockettes Begins March 12 at Radio City Music Hall It isn’t spring until the snow melts and the tourists start wearing their double-pleated shorts/white walking shoes combo. The crappy weather still doesn’t dim our excitement for the Rockettes’ New York Spring Spectacular. The new show features Tony winner Laura Benanti, Derek Hough of Dancing with the Stars, and, of course, the Rockettes in a story of three New Yorkers who change each other’s lives. Expect 3-D special effects, large-scale puppetry, and glorious gams. Click for tickets! Hey, you, hitting the gym for spring break—why bother? Things are getting good in New York. High-profile shows are opening left and right and the weather doesn’t resemble the inside of your freezer anymore. (Well, it kinda still does, but it’s almost over!) This week features the debut of three new musicals, and a night of stars performing for charity and more. Stay where you are, and bask in this week’s picks! Celebrate Broadway Opposite Day March 9 at the Al Hirschfield Theatre Being philanthropic is usually a one-way street. Broadway goes both ways. When you make a donation, you get entertained! With the 10th anniversary of Broadway Backwards, your ticket fee not only supports BC/EFA and the Lesbian, Gay, Bisexual & Transgender Community Center of New York City, you get gender-reversed performances from all-stars like Norm Lewis, Tony Yazbeck, Lena Hall, and more. Top that, UNICEF! Your move, March of Dimes! Click for tickets!
Idina Menzel is bringing Liz/Beth—cardigan, blazer and all—on the road in the national tour of If/Then! We’re giving you the chance to fly out to catch the show at the Segerstrom Center for the Arts in Costa Mesa, California (airfare and hotel included), and all you have to do is belt your brains out for the Tony and Broadway.com Audience Choice Award winner.In the second act of the Tom Kitt and Brian Yorkey musical, Elizabeth delivers her big number, “Always Starting Over.” But why should she be the only one who gets to sing it? Post your own cover of the song on YouTube and share it with us for your chance to see Menzel sing it live on stage in If/Then.Contestants have until 3PM on October 8 to submit their performances. The next day, up to five finalists will be revealed, and the general public will vote for their favorite. Menzel, who kicks off the tour on October 13 in Denver, Colorado, will announce the winner on Broadway.com on October 20.Get the rundown from original Broadway cast member Jackie Burns below, then CLICK HERE TO SUBMIT YOUR VIDEO and get all the info you need. Remember to warm up first! Star Files Idina Menzel View Comments
Jack Black’s just pledged allegiance to the band! The creator and headliner of the hit 2003 movie School of Rock stopped by Andrew Lloyd Webber’s stage adaptation for the first time on May 1. “It’s surreal,” Black told Broadway.com. “I had lots of déjà vu and lots of powerful moments of pride to be part of something that has transformed into this incredible Broadway masterpiece.”The musical stars Alex Brightman in Black’s role of wannabe rock star Dewey Finn. “There’s no way I could have done it that well. He really made it his own and he took it to another level,” said Black. Brightman revealed: “We’ve been waiting for him and he stayed away for great reasons. He wanted to let the show be its thing and now he came and this was one of the best shows we’ve done!””It’s just so emotional,” added Sierra Boggess, who plays headmistress Rosalie Mullins in the tuner, about Black’s attendance.”My hope is that he feels that we really honored him.” We think it’s safe to say the three-time Broadway.com Audience Choice Award winner’s wish came true. Added Black: “I was laughing, I was crying and I was rocking!”Directed by Laurence Connor and featuring new music written by Lloyd Webber and lyricist Glenn Slater, with a book by Julian Fellowes, the production is playing at the Winter Garden Theatre. Sierra Boggess, Alex Brightman, Sammy Black & Jack Black(Photo: Emilio Madrid-Kuser) View Comments Related Shows School of Rock – The Musical Show Closed This production ended its run on Jan. 20, 2019
By Rebecca AyerUniversity of GeorgiaAthens, Ga. – Researchers at the University of Georgia have beenawarded a $425,598 subcontract to develop a human embryonicstem-cell–derived test for screening drugs capable of treatingspinal muscular atrophy, the No. 1 genetic killer of childrenunder 2 years old.The subcontract was awarded through the Spinal Muscular AtrophyProject to speed up the process of developing safe and effectivetreatment of SMA.The SMA Project is a model translation program established by theNational Institute of Neurological Disorders and Stroke at theNational Institutes of Health. Its goal is to identify andcomplete preclinical research and develop candidate therapeuticsfor treating SMA by late 2007.The UGA team hopes to have the first assay ready in one year.”All the talk surrounding stem cell research has focused on celltherapy,” said Steven Stice, one of UGA’s Georgia ResearchAlliance Eminent Scholars and the project’s principalinvestigator.”We hope this will be the first use of human embryonic stem cellsin human medicine,” Stice said. “Our goal is to have an immediateimpact on health issues through better ways of identifyingpromising drug therapies for diseases like SMA.”Spinal muscular atrophy is a group of inherited and often fataldiseases that destroys the nerves necessary for voluntary musclemovement, such as crawling, walking, head and neck control andeven swallowing.According to the NIH, one in every 40 people is a genetic carrierof the disease. One in 6,000 babies is born with it. And of thechildren diagnosed before age 2, half will die before theirsecond birthday.SMA is caused by a defect in the survival motor neuron gene 1(SMN1), which produces a protein necessary for all of the body’smotor neurons to develop and function.In people with SMA, limited amounts of SMN protein are providedby a second SMN gene (SMN2) and allow for the correct functioningof most of the body’s cells.However, the reduced protein levels produced by SMN2 aren’tenough to keep the neurons in the spinal cord from degenerating.Transgenic mouse models developed to study SMN function have beeninformative, Stice said. However, typical model systems, such asthe mouse, possess only one SMN gene. And research has found thatthe initial survival of human SMA patients depends on proteinproduced by the SMN2 gene, found only in humans.”The unique sensitivity of spinal motor neurons and configurationof SMN genes in humans make it essential for us to create abetter model to study the disease,” Stice said. “And the bestmodel would be a human one.”Stice and his group will establish two different, butcomplementary, human motor neuron systems using mixed motorneuron cultures derived using NIH-approved embryonic stem celllines owned and distributed by BresaGen, a private researchcompany in Athens.The cell-culture–based systems will be designed to test candidatedrugs’ ability to increase SMN protein levels.”We have good candidate drugs from studies in other systems,”said Michael Terns, associate professor of biochemistry andmolecular biology at UGA. “In addition, there are libraries ofcompounds available for testing to see if protein concentrationsgo up without having to know the mechanism behind it.”Michael and Rebecca Terns, both advisors on the SMA Projectcontract, have been studying the molecular functions of SMN1since their laboratory first cloned the gene in 1996.The Terns recently received a $300,000 supplement to theirexisting grant from the NIH to specifically examine the functionof SMN in motor neurons.”What our lab is trying to understand is why only spinal motorneurons are affected by a mutation in SMN when the gene isinvolved in mechanisms required for all cell functioning,” Ternssaid.(Rebecca Ayer is an information specialist with the Universityof Georgia Biomedical and Health Sciences Institute.)
By Stephanie SchupskaUniversity ofGeorgiaFour times Hamilton Jordan has battled cancer. Each time he’s diagnosed, he researches his disease and hopes for new treatments.The scientists, politicians and lawyers gathered on the University of Georgia campus Monday believe some of those treatment answers lie in stem cell research.”Life never meant so much to me over the last few years as the years when I’m fighting for it,” Jordan said as the former White House chief of staff shared his cancer stories.Stem cell research brings to mind images of lab coats and microscopes. But Monday’s symposium brought to light the legal, political and personal issues facing stem cell research. Lawyer Sherry Knowles, U.S. Congressman Tom Price and Jordan came to discuss their respective points of view.”These are three very important topics that will really determine how medicine will reach the public,” said Steve Stice, a Georgia Research Alliance eminent scholar and director of UGA’s Regenerative Bioscience Center.Every year, UGA holds a “Human Embryonic Stem Cell Toolbox” workshop, a five-day clinic sponsored by the National Institutes of Health. Participants come from as far away as Japan.The RBC then holds the symposium to “advance public knowledge and awareness of genetic medicine,” Stice said.Jordan, a key figure in President Jimmy Carter’s administration, was diagnosed with histiocytic lymphoma in 1985 after an X-ray showed a golf-ball-sized tumor in his chest.”The doctor said it was likely cancer,” he said. As he waited for the results of his biopsy, “my wife, mom and sister took turns crying for three days as I lay there.”After he was diagnosed, Jordan “went into a funk. I was scared to death. I kind of cut myself off from my family.”Then a doctor friend from UGA dropped by for a visit at the hospital and asked him: “Who is going to have a greater decision in your life than yourself?”That night, Jordan went down to the hospital’s library and started learning about his cancer.The personal side plays a huge role in the research. But researchers must also keep in mind the legal aspects of stem cells.As a partner at King and Spalding, Knowles focuses heavily on protecting biotechnology patent portfolios. “You can do all the research you want, but if you’re blocked by patents, you’ll get nowhere,” she told the scientists. “I help get companies and universities through the patent thicket.”As of June 2005, 1,400 patents covered the various aspects of stem cell research. That makes it all the more important for scientists to investigate what has been patented and to get the proper licenses before proceeding with studies.Although Rep. Tom Price (R-Ga.) is an orthopedic surgeon and third-generation physician, “I’m here to give you opinion,” he said. He believes that stem cells, whether embryonic or adult, hold great promise for many diseases and many illnesses. Then he went on to explain the political dilemma.”Politicians like unanimity,” he said. “We don’t like controversy. … We try to help people and make people happy.”And stem cell research, especially embryonic research, is controversial. “With adult and cord cell research, you get into the whole area of political demagoguery,” Price said. “Oftentimes it seems in embryonic stem cells that the secret to so many diseases is just months away. This does a disservice to the public, science and those suffering from diseases.”Plus, “the government is not nimble,” he said. “You can’t get us to move in such a way that responds quickly to issues.”He asked the scientists to educate their politicians, to invite them into the lab and explain their research. It helps to add a personal view to something as tiny as cells.”I look at every day differently than before I had these experiences,” Jordan said of his battles with cancer. To him, stem cell research is “important to our country, our people and our economy. There’s so much to lose here.”(Stephanie Schupska is a news editor with the University ofGeorgia College of Agricultural and Environmental Sciences.)
“They’re a lot of fun to be around,” Rymer said. He travels daily from his home in Kennesaw to attend classes at UGA and to teach.Weiglein asked for a Project FOCUS teacher because she saw how the program helped another class. “They were always doing interesting things out in the hall with the students,” Weiglein said. “I wanted my students to have that … they’re always asking, ‘Is Mr. Gary coming?’”FOCUS students have also learned to appreciate their partner teachers. “The kids are the best thing about this program, and my teacher that I work with,” said Caitlin Walther, a senior psychology, pre-nursing major from Atlanta. “She is a saint in my eyes and has restored my faith in teachers.”“Project FOCUS has given me a newfound respect for teachers,” said Tripp Wall, a fourth-year biology, pre-med major from Toccoa. He plans to become an anesthesiologist. “I never realized how much of a pain it could be to teach a classroom of students. I never realized that some students just cannot learn as fast as others.”FOCUS helps students “improve their communication skills,” Knauft said. “If you can manage a class full of third graders … you learn to do a lot of thinking on your feet.”The program also has students analyzing teaching methods. “Because the UGA students do a lot of active teaching, they’ve become a lot less tolerant of poor teaching in their own UGA courses,” Knauft said. Hugs for gradesProject FOCUS helps promote science in a positive way to elementary students and teachers who work with UGA students. This positive emphasis has its rewards. “I get hugs for grades,” said Renee Pascale, a junior biology education major from Atlanta. “No other class has that in the curricula.”Back in Weiglein’s classroom, Rymer gets comments like: “Wow, you’re a giant.”“I can sum [the experience] up like this,” he said. “I have been blessed in so many ways. I found a way I could help. I believe that these kids will someday be involved in shaping our nation. If I can be a positive influence, and help better someone’s life, why not?”(Stephanie Schupska is a news editor with the University ofGeorgia College of Agricultural and Environmental Sciences.) Teacher appreciationRecently, children studied different ecosystems in Wendy Weiglein’s kindergarten classroom at South Jackson Elementary School. During science center time, Rymer passed around rocks and shells with his group of four students. By Stephanie SchupskaUniversity ofGeorgiaPaper people and artwork dance from the ceiling as Gary Rymer asks kindergarteners a question. During most of the University of Georgia senior’s courses he listens to lectures and participates in labs. In his Project FOCUS class, he’s the teacher.Project FOCUS – Fostering Our Community’s Understanding of Science – is a partnership between school districts and UGA, said David Knauft, a UGA College of Agricultural and Environmental Sciences professor. This partnership is increasingly important as schools struggle to meet federal government requirements in adequate yearly progress. AYP includes improvements in science test scores in middle and high schools.“As of right now, there is no high stakes testing for science in the elementary schools, so teachers spend more time working with reading, math and language arts,” he said. “Our students help the teachers give more emphasis to sciences.“One thing we realize is that the FOCUS students don’t always go back in the class for a second semester.” But after a UGA student has taught, the elementary school students are more “excited about science. The children tell our FOCUS students that they want to grow up and be scientists, just like the UGA students.”In 2002, Knauft helped start the semester-long program in which UGA students teach elementary students science two days per week. FOCUS enrolled 40 students for the fall semester. The program, which started at Barnett Shoals Elementary School in Athens, Ga., now extends to several other schools.Undergraduates must have 12 hours of science courses and a 2.5 GPA to apply, but Knauft sees majors varying from genetics to marketing.
University of GeorgiaPresident George W. Bush this week announced his intention tonominate Gale A. Buchanan to be Under Secretary of Agriculturefor Research, Education and Economics. Buchanan is dean anddirector emeritus of the University of Georgia College ofAgricultural and Environmental Sciences.Buchanan served as UGA CAES dean and director of CooperativeExtension, Agricultural Experiment Stations and Academic Affairsfrom March 1995 until December 2004, when he returned to theclassroom to teach until his retirement in April 2005.Before that, Buchanan was associate director of the GeorgiaAgricultural Experiment Stations and resident director of theCAES Coastal Plain Experiment Station in Tifton, Ga. He spent 21years with Auburn University in the department of agronomy andsoils, with primary teaching and research responsibilities inweed science.He served as dean and director of the Alabama AgriculturalExperiment Station from October 1980 to September 1985.Buchanan served in the Alabama Army National Guard for more than25 years, reaching the rank of colonel.He received his bachelor’s and master’s degrees from theUniversity of Florida and his Ph.D. from Iowa State University.